IP Library › Granted Patent US 10,105,357
Granted Patent B2
US 10,105,357 · App. 15/521,517 · Granted Oct 23, 2018

Indication of antibiotic drugs for preparation of cancer inhibition pharmaceutical composition

Inventors: Chiu-Hung Chen (Kaohsiung, TW); Show-Mei Chuang (Taichung, TW); Nai-Wan Hsiao (Taichung, TW); Ruei-Yue Liang (Taichung, TW); Xiao-Tong Tan (Taichung, TW)
Assignee: LAUNX BIOMEDICAL CO., LTD.
A61K31/4427A61K31/085A61K31/137A61K31/138A61K31/196A61K31/197A61K31/216A61K31/341A61K31/366A61K31/381A61K31/404A61K31/4525A61K31/505A61K31/549A61K31/55A61K31/7056A61K38/02A61K38/05A61K38/14A61K45/06C07C211/27C07C211/30A61K31/00A61K38/00A61K2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,105,357
App. No.
15/521,517
Granted
Oct 23, 2018
Kind
B2
Abstract

A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of an antibiotic drug or a pharmaceutical acceptable salt thereof. The antibiotic drug is selected from the group consisting of an aminoglycoside antibiotic drug, an anti-fungal antibiotic drug, a Cephalosporin antibiotic drug, a β-propionamide antibiotic drug, a chloramphenicol antibiotic drug, an erythromycin antibiotic drug, a penicillin antibiotic drug, and a tetracycline antibiotic drug.. The cancer is selected from the group consisting of lung cancer, gastrointestinal tract cancer, colorectal cancer, prostate cancer, bladder cancer, cervical cancer, breast cancer, and blood cancer.

Claims (1)

1. A method for treating a cancer comprising: administering to a subject in need thereof a pharmaceutical composition comprising a therapeutically effective amount of thonzonium bromide or a pharmaceutical acceptable salt thereof, wherein the cancer is selected form the group consisting of lung cancer, gastrointestinal tract cancer, colorectal cancer, kidney cancer, tongue squamous cell carcinoma, osteosarcoma, bladder cancer, cervical cancer, breast cancer, blood cancer, skin cancer, liver cancer, pancreatic cancer, ovarian cancer, and combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2018
From: CHEN, CHIU-HUNG
To: LAUNX BIOMEDICAL CO., LTD.
Reel/Frame 047094/0370 →
Continuity (2)
Provisional Application 62068298 · Oct 24, 2014
Related Publication 20170304387A1 · Oct 26, 2017
Cited By (1)
US 12,233,073